Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

tGLI1 as a Therapeutic Target in Brain Metastases: A Window of Opportunity Study in Breast Cancer Brain Metastases and Primary Gliomas

NCT03796273 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT03796273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03796273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
tGLI1 as a Therapeutic Target in Brain Metastases: A Window of Opportunity Study in Breast Cancer Brain Metastases and Primary Gliomas
Lead sponsor
Wake Forest University Health Sciences
Phase
Phase 1
Overall status
Terminated
Start date
March 13, 2019
Completion date
October 23, 2022
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anatomic stage iv breast cancer ajcc v8, astrocytoma, breast carcinoma metastatic in the brain, glioma, invasive breast carcinoma, oligodendroglioma, prognostic stage iv breast cancer ajcc v8, recurrent glioma